Business · 14/03/2022Updated: 10/17/2026 · 1 min read
FDA Classifies Interoperable Automated Glycemic Controller as Class II Device with Special Controls
Summary
The FDA has classified the interoperable automated glycemic controller as a Class II device with special controls, aiming to ensure its safety and effectiveness while expanding patients' access to innovative devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →